Bausch Health Companies Inc (BHC US, +1, 14-Aug-25)
We ranked this stock +N on June 13th based on a $14.7 million purchase (2.9 million shares) from John Paulson (Non-Executive Chair since 2022, Director since 2017) at $5.27.
The purchase was indirect for Paulson Capital, increasing their holdings by 11%. At the time, we noted “his last and only other reported purchase was in May 2020 at $16. Paulson has also been a director at Bausch + Lomb (BLCO) since 2022. Bausch Health owns 88% of BLCO. This is an unusual purchase from a long-time director.”
The stock has moved higher since that timely buy, and yet he has made two additional, even larger purchases. On June 13th, he bought 3.6 million shares at $5.94, and two months later, on August 13th, he purchased 3.2 million shares at $6.56. These additional purchases totaling $42.4 million, also indirect for Paulson Capital, increase their holdings to 36 million shares, 9.7% of the company.
We are further upgrading the stock, from +N to +1, due to this aggressive buying from Paulson.
If you want the Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe! Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.
